Punch & Associates Investment Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-7,911
Closed -$457K 186
2023
Q4
$457K Hold
7,911
0.03% 183
2023
Q3
$418K Buy
7,911
+100
+1% +$5.25K 0.03% 181
2023
Q2
$422K Hold
7,811
0.03% 183
2023
Q1
$391K Hold
7,811
0.03% 178
2022
Q4
$361K Sell
7,811
-5,800
-43% -$251K 0.02% 186
2022
Q3
$527K Hold
13,611
0.04% 177
2022
Q2
$507K Buy
13,611
+4,000
+42% +$163K 0.04% 182
2022
Q1
$426K Hold
9,611
0.02% 191
2021
Q4
$408K Sell
9,611
-1,800
-16% -$75.6K 0.02% 200
2021
Q3
$495K Hold
11,411
0.03% 189
2021
Q2
$488K Hold
11,411
0.03% 192
2021
Q1
$441K Hold
11,411
0.03% 199
2020
Q4
$410K Hold
11,411
0.03% 194
2020
Q3
$436K Hold
11,411
0.04% 194
2020
Q2
$401K Hold
11,411
0.04% 191
2020
Q1
$372K Hold
11,411
0.04% 182
2019
Q4
$516K Hold
11,411
0.04% 181
2019
Q3
$464K Hold
11,411
0.04% 181
2019
Q2
$490K Hold
11,411
0.04% 177
2019
Q1
$438K Hold
11,411
0.04% 179
2018
Q4
$403K Hold
11,411
0.04% 191
2018
Q3
$439K Hold
11,411
0.03% 187
2018
Q2
$373K Hold
11,411
0.03% 183
2018
Q1
$312K Buy
+11,411
New +$310K 0.03% 175

Other funds holding BSX

Punch & Associates Investment Management's BSX Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 7,911 shares — an estimated $457K sold.

Punch & Associates Investment Management first reported a position in BSX in Q1 2018 and held it in 24 quarters. The position peaked at $527K in Q3 2022. 1,223 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Punch & Associates Investment Management reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Punch & Associates Investment Management sold 7,911 Boston Scientific shares in Q1 2024, an estimated $457K.
  • Punch & Associates Investment Management first reported a position in Boston Scientific in Q1 2018 and held it in 24 quarters.
  • Punch & Associates Investment Management's Boston Scientific position peaked at $527K in Q3 2022.
  • 1,223 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.